Generic Symbicort, over-the-counter rescue inhalers, long COVID lung symptoms

April 01, 2022

2 minute read


We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

The editors at Healio have compiled the most read respiratory news published in March.

Highlights include FDA approval of first generic Symbicort for asthma and COPD; a study that found that small airway disease can persist for many people with long COVID; a call to move to over-the-counter availability of asthma reliever inhalers; research linking higher BMI to favorable outcomes in cystic fibrosis; and more.



Source: Adobe Stock.

Read these articles, and more, below, in no particular order.

Small airway disease may linger for many with long COVID

According to a single-center study published in Radiology. Read more

A call to move to over-the-counter availability of asthma reliever inhalers

In a viewpoint published in JAMAthe authors propose that the shift to the availability of over-the-counter rescue inhalers would provide asthma patients with access to safer and more effective rescue therapy than is currently available over-the-counter. Read more

FDA approves first generic Symbicort for asthma, COPD

The FDA announced approval of the first generic Symbicort – Budesonide and Formoterol Fumarate Dihydrate – Inhalation Aerosol for the treatment of asthma and COPD, according to a press release from the agency. Read more

‘Demonstrable’ decline in lung function over 10 years in former current smokers: COPDGene

Ten-year follow-up data from the COPDGene study show that changes in lung function, respiratory symptom burden, and functional capacity in current and former smokers appear to be slow. Read more

Common house dust allergen exposures in patients with COPD

Exposures to house dust allergens are common in COPD patients and exposure is associated with adverse effects in those who also have allergen sensitization, researchers reported in American Journal of Respiratory and Critical Care Medicine. Read more

Acute respiratory failure in infancy may affect long-term neurocognitive outcomes

Survival to intensive care hospitalization for acute respiratory failure and to discharge without severe cognitive dysfunction in infancy was associated with significantly lower later IQ scores than matched siblings. Read more

Higher BMI associated with favorable clinical outcomes in patients with cystic fibrosis

In a systematic review and meta-analysis, researchers found that higher BMI was associated with favorable clinical outcomes in patients with cystic fibrosis, prompting reconsideration of the currently recommended target BMI. Read more

Portable ultrasound useful for estimating right atrial pressure in the clinic

Right atrial pressure estimated by a portable ultrasound machine was consistent with B-type natriuretic peptide and was an independent predictor of clinical worsening in patients with pulmonary hypertension. Read more

Adding azithromycin to standard care improves asthma control and exacerbations in children

Adding oral azithromycin to standard therapy improved asthma control and reduced exacerbations compared with standard therapy alone in children with poorly controlled asthma. Read more

Venovenous ECMO for severe COVID-19 led to sustained ‘exceptional early survival’

Patients with severe COVID-19 who received venovenous extracorporeal membrane oxygenation support had “exceptional early survival” to discharge that was sustained 1 year after cannulation. Read more